INDEGENE
|
The Current P/B Ratio of INDEGENE is 3.96.
| Share Price | ₹515.9 | May 15,2026 |
| Market Cap | ₹12,426.8 Cr | |
| Book Value | ₹3,138.7 Cr | Mar2026 - Consolidated Results |
| Price/Book | 3.96x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of INDEGENE
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹12,426.8 Cr] as on May 15,2026
(/) Book Value [ ₹3,138.7 Cr] based on Mar2026 - Consolidated Results
(=) P/B Ratio [ 3.96x ]
Thus, for INDEGENE , the investors are currently willing to pay '3.96 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of INDEGENE !
The chart below summarizes the trend in P/B Ratio of INDEGENE over the last five years.
Historical PB (Price/Book ) ratio chart of INDEGENE
PB Ratio Performance Analysis for INDEGENE
- INDEGENE 's p/b ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.07x.
- INDEGENE 's operated at median p/b ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, INDEGENE 's p/b ratio peaked in Mar2025 at 5.37x.
- INDEGENE 's p/b ratio hit its five-year low in Mar2024 of 0x.
How does INDEGENE 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| INDEGENE | 3,138.70 | 3.96 | 12,426.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 72,218.00 | 6.25 | 451,075.0 |
| DIVIS LABORATORIES LTD | 14,969.00 | 11.99 | 179,486.0 |
| CIPLA LTD | 34,431.90 | 3.36 | 115,641.0 |
| TORRENT PHARMACEUTICALS LTD | 7,590.69 | 19.65 | 149,124.0 |
| DR REDDYS LABORATORIES LTD | 37,891.50 | 2.94 | 111,589.0 |
| MANKIND PHARMA LTD | 14,288.70 | 7.23 | 103,368.0 |
| ZYDUS LIFESCIENCES LTD | 23,953.10 | 4.25 | 101,755.0 |
| LUPIN LTD | 22,448.30 | 4.63 | 103,966.0 |
| AUROBINDO PHARMA LTD | 32,653.30 | 2.66 | 86,956.9 |
| ABBOTT INDIA LTD | 4,774.19 | 12.43 | 59,359.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs INDEGENE 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | 2.66x |
| Max industry PB | 19.65x |
| Median industry PB | 4.63x |
| Average industry PB | 7.21x |
You may also like the below Video Courses